The present work is aimed to identify the inhibitors for insulin-degrading enzyme (IDE) from plant secondary metabolites through in-silico studies. IDE is a protease that cleaves insulin and other bioactive peptides such as amyloid-β. IDE is the important drug target for diabetes because IDE is the principal insulin-degrading protease in vivo, IDE inhibitors should enhance insulin signaling and thus have efficacy in relevant animal models of diabetes and also in therapy. The in-silico absorption distribution metabolism elimination screening was carried out to find out the drug likeness properties of selected flavonoids. In-silico molecular docking simulations have been performed to positional phytoconstituents into the preferred binding site of the protein receptor IDE, to predict the binding modes, the binding affinities and the orientation of all ligands. The docking studies revealed that all compounds showed good docking score. In-silico molecular docking simulations have been performed to positional phytoconstituents into the preferred binding site of the protein receptor IDE, to predict the binding modes, the binding affinities and the orientation of all ligands. The docking studies revealed that all compounds showed good docking score. The prediction of the binding affinity of a new compound to an identified target is a significant parameter in the development of a new drug. It is found that the flavonoids quercetin, genistein, wogonin, isorhamnetin and luteolin had drug like properties rutin and Diosmin are in good bioavailability radar and diosmin, wogonin and flavilium elicit a higher binding affinity with IDE.
Dharmaraj S, Negi P, Esakkimuthukumar M, Swaroop AK, Jubie S. Identification of suitable flavonoids as insulin degrading enzyme inhibitors through in-silico approach. J Appl Pharm Sci, 2023; 13(Suppl 1):051–064. https://doi.org/10.7324/JAPS.2023.137481
Baell JB, Holloway GA. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem, 2010; 53:2719-40. https://doi.org/10.1021/jm901137j | |
Brito Sanchez Y, Marrero-Ponce Y, Barigye SJ, Yaber Goenaga I, Morell Prez C, Le-Thi-Thu H, Cherkasov A. Towards better BBB passage prediction using an extensive and curated data set. Mol Inform, 2015; 34(5):308-30. https://doi.org/10.1002/minf.201400118 | |
Cheng T, Zhao Y, Li X, Lin F, Xu Y, Zhang X, Li Y, Wang R, Lai L. Computation of octanol water partition coefficients by guiding an additive model with knowledge. J Chem Inform Model, 2007; 47:2140-8. https://doi.org/10.1021/ci700257y | |
Daina A, Michielin O, Vincent Z. SwissADME: a free web tool to evaluate pharmacokinetics, drug likeness and medicinal chemistry friendliness of small molecules. Nat Sci Rep, 2017; 7:1-13. https://doi.org/10.1038/srep42717 | |
Darvas F, Keseru G, Papp A, Dorman G, Urge L, Krajcsi P. In silico and ex silico ADME approaches for drug discovery. Top Med Chem, 2002; 2:1287-304. https://doi.org/10.2174/1568026023392841 | |
Di L, Artursson P, Avdeef A, Ecker GF, Faller B, Fischer H, Houston JB, Kansy M, Kerns EH, Krämer SD, Lennernäs H, Sugano K. Evidence-based approach to assess passive diffusion and carrier-mediated drug transport. Drug Discov Today, 2012; 17(15-6):905-12. https://doi.org/10.1016/j.drudis.2012.03.015 | |
Ega W, Mer KM, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem, 2000; 43(21):3867-77. https://doi.org/10.1021/jm000292e | |
Gleeson MP, Hersey A, Hannongbua S. In-silico ADME models a general assessment of their utility in drug discovery applications. Curr Topic Med Chem, 2011; 11(4):358-81. https://doi.org/10.2174/156802611794480927 | |
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev, 1997; 23:3-5. https://doi.org/10.1016/S0169-409X(96)00423-1 | |
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev, 2001; 46(1-3):3-26. https://doi.org/10.1016/S0169-409X(96)00423-1 | |
Lombardo F, Gifford E, Shalaeva MY. In silico ADME prediction: data, models, facts and myths. Mini Rev Med Chem, 2003; 3:861-75. https://doi.org/10.2174/1389557033487629 | |
Mahanthesh MT, Ranjith, Yaligar R, Jyothi R, Narappa G, Ravi MV. Swiss ADME prediction of phytochemicals present in Butea monosperma (Lam.) Taub. J Pharm Phytochem, 2020; 9(3):1799-809. | |
Moriguchi I, Shuichi H, Nakagome I, Hirano H. Comparison of reliability of log P values for drugs calculated by several methods. Chem Pharm Bull, 1994; 42:976-8. https://doi.org/10.1248/cpb.42.976 | |
Ogu CC, Maxa JL. Drug interactions due to cytochrome P450. Proc (Bayl Univ Med Cent), 2000; 13(4):421-3. https://doi.org/10.1080/08998280.2000.11927719 | |
Wildman SA, Crippen GM. Prediction of physicochemical parameters by atomic contributions. J Chem Inform Model, 1999; 39:868- 73. https://doi.org/10.1021/ci990307l | |
Yalkowsky SH, Valvani SC. Solubility and partitioning I: solubility of nonelectrolytes in water. J Pharm Sci, 1980; 69:912-22. https://doi.org/10.1002/jps.2600690814 | |
Yi F, Li L, Xu LJ, Meng H, Dong YM, Liu HB, Xiao PG. In silico approach in reveal traditional medicine plants pharmacological material basis. Chinese Med J, 2018; 13(33):1-20. https://doi.org/10.1186/s13020-018-0190-0 |
Year
Month